Literature DB >> 16730983

Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: synthesis and biological evaluation.

Fabrizio Micheli1, Alessandra Pasquarello, Giovanna Tedesco, Dieter Hamprecht, Giorgio Bonanomi, Anna Checchia, Albert Jaxa-Chamiec, Federica Damiani, Silvia Davalli, Daniele Donati, Chiara Gallotti, Marcella Petrone, Marilisa Rinaldi, Graham Riley, Silvia Terreni, Martyn Wood.   

Abstract

Within the continuous quest for the discovery of novel compounds able to treat anxiety and depression, the generation of a pharmacophore model for 5-HT2C receptor antagonists and the discovery of a new class of potent and selective 5-HT2C molecules are reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730983     DOI: 10.1016/j.bmcl.2006.05.034

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Insights into binding modes of 5-HT2c receptor antagonists with ligand-based and receptor-based methods.

Authors:  Chunhua Lu; Fangfang Jin; Cui Li; Weihua Li; Guixia Liu; Yun Tang
Journal:  J Mol Model       Date:  2011-01-04       Impact factor: 1.810

2.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

3.  Feasible Synthesis of Antagonist of GPR40 by Constructing 2-Thiouracil Ring viaAcid Mediated Cyclization.

Authors:  Yongfeng Zhao; Yang Song; Xiulin Shen; Jiayu Liao
Journal:  Heterocycles       Date:  2011-05-01       Impact factor: 0.831

4.  Synthesis, bioactivity, 3D-QSAR studies of novel dibenzofuran derivatives as PTP-MEG2 inhibitors.

Authors:  Ying Ma; Hui-Yu Wei; Yu-Ze Zhang; Wen-Yan Jin; Hong-Lian Li; Hui Zhou; Xian-Chao Cheng; Run-Ling Wang
Journal:  Oncotarget       Date:  2017-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.